Sotera Health Co. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1287154,
    "name": "Sotera Health Co.",
    "stock_name": "Sotera Health Co.",
    "full_name": "Sotera Health Co.",
    "name_url": "stocks-analysis/sotera-health-co",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "16.56",
    "chg": -0.37,
    "chgp": "-2.19%",
    "dir": -1,
    "prev_price": "16.93",
    "mcapval": "4,568.82",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US83601L1026",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "12.35 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sotera-health-co-1287154-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sotera Health Co. Hits New 52-Week High at $17.78",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotera-health-co-hits-new-52-week-high-at-1778-3674065",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SoteraHealthCo_priceRelatedfactors_3674065.png",
        "date": "2025-11-05 16:52:12",
        "description": "Sotera Health Co. achieved a new 52-week high of USD 17.78 on November 4, 2025, marking a notable performance in the Pharmaceuticals & Biotechnology sector. The company has seen a 37.6% growth over the past year, with a P/E ratio of 36.00 and a return on equity of 19.00%."
      },
      {
        "title": "Sotera Health Co. Hits New 52-Week High of $17.15",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotera-health-co-hits-new-52-week-high-of-1715-3649303",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/SoteraHealthCo_priceRelatedfactors_3649303.png",
        "date": "2025-10-27 17:02:23",
        "description": "Sotera Health Co. achieved a new 52-week high of USD 17.15 on October 24, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen a 41.21% growth over the past year and maintains a P/E ratio of 36.00 and a return on equity of 19.00%."
      },
      {
        "title": "Sotera Health Co. Experiences Revision in Stock Evaluation Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotera-health-cos-technical-trend-changes-from-bullish-to-mildly-bullish-amid-stock-price-increase-3620021",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/SoteraHealthCo_technicaldot_3620021.png",
        "date": "2025-10-14 16:30:41",
        "description": "Sotera Health Co., a small-cap in the Pharmaceuticals & Biotechnology sector, has seen a recent stock price increase to $15.67. Over the past year, it has returned 2.28%, while achieving a notable 129.43% return over three years. Technical indicators suggest a bullish trend, reflecting its market resilience."
      },
      {
        "title": "Is Sotera Health Co. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-sotera-health-co-technically-bullish-or-bearish-3617691",
        "imagepath": "",
        "date": "2025-10-14 11:38:34",
        "description": "As of 10 October 2025, the technical trend for Sotera Health Co. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating a positive momentum. The Bollinger Bands are also showing a mildly bullish stance in both weekly and monthly time frames. However, the Dow Theory indicates a mildly bearish trend on the weekly chart, which adds some caution. \n\nIn terms of returns, Sotera Health has outperformed the S&P 500 year-to-date with a return of 14.55% compared to 11.41%, but it has lagged over the past year with a return of 2.28% versus 13.36% for the index. Overall, the current technical stance is mildly bullish, driven by positive MACD and Bollinger Bands, despite some bearish signals from the Dow Theory and OBV...."
      },
      {
        "title": "Is Sotera Health Co. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-sotera-health-co-technically-bullish-or-bearish-3614688",
        "imagepath": "",
        "date": "2025-10-13 11:40:14",
        "description": "As of 10 October 2025, the technical trend for Sotera Health Co. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating a positive momentum. The Bollinger Bands also reflect a mildly bullish stance in both weekly and monthly time frames. However, the Dow Theory shows a mildly bearish signal on the weekly chart, and the On-Balance Volume is mildly bearish as well, suggesting some selling pressure.\n\nIn terms of returns, Sotera Health has outperformed the S&P 500 year-to-date with a return of 12.21% compared to the S&P 500's 11.41%, but it has underperformed over the past year, returning only 0.99% versus the S&P 500's 13.36%. Overall, the current technical stance is mildly bullish, but with some mixed signals indicating caution...."
      },
      {
        "title": "Is Sotera Health Co. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-sotera-health-co-technically-bullish-or-bearish-3613021",
        "imagepath": "",
        "date": "2025-10-12 11:27:54",
        "description": "As of 10 October 2025, the technical trend for Sotera Health Co. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating a positive momentum. The Bollinger Bands are also showing a mildly bullish stance in both weekly and monthly time frames. However, the Dow Theory presents a mildly bearish signal on the weekly chart, and the On-Balance Volume (OBV) is mildly bearish as well, suggesting some selling pressure.\n\nIn terms of performance, Sotera Health has underperformed the S&P 500 over the past week and month, with returns of -3.76% and -2.48% compared to -2.43% and 0.31% for the index, respectively. However, it has outperformed the S&P 500 year-to-date with a return of 12.21% versus 11.41%. Over three years, Sotera Health significantly outperformed the benchmark with a return of 120.55% compared to 81.39%.\n\nOverall, the current technical s..."
      },
      {
        "title": "Is Sotera Health Co. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-sotera-health-co-technically-bullish-or-bearish-3547830",
        "imagepath": "",
        "date": "2025-09-20 20:04:01",
        "description": "As of 28 August 2025, the technical trend for Sotera Health Co. has changed from mildly bullish to bullish. The current stance is bullish, with key indicators supporting this view including a bullish MACD on the weekly timeframe and bullish moving averages on the daily timeframe. However, the weekly RSI is bearish, indicating some short-term weakness. The company has a year-to-date return of 16.74%, outperforming the S&P 500's 12.22%, but it has underperformed over the past year with a return of -4.6% compared to the S&P 500's 17.14%. Overall, the strength of the bullish trend is supported by the weekly KST and Dow Theory both indicating bullish conditions...."
      },
      {
        "title": "Is Sotera Health Co. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-sotera-health-co-overvalued-or-undervalued-3544080",
        "imagepath": "",
        "date": "2025-09-20 18:37:07",
        "description": "As of 7 July 2025, the valuation grade for Sotera Health Co. has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company appears overvalued based on its current metrics, with a P/E ratio of 36, a Price to Book Value of 8.52, and an EV to EBITDA of 10.60. In comparison, peers such as Lantheus Holdings, Inc. have a much lower P/E ratio of 10.13, and Haemonetics Corp. shows a more attractive EV to EBITDA of 10.38, highlighting the disparity in valuation.\n\nRecent stock performance shows that Sotera Health Co. has underperformed against the S&P 500 over the past year, with a return of -4.6% compared to the index's 17.14%. This underperformance, coupled with the elevated valuation ratios, reinforces the conclusion that Sotera Health Co. is overvalued in the current market environment...."
      }
    ],
    "total": 12,
    "sid": "1287154",
    "stock_news_url": "https://www.marketsmojo.com/news/sotera-health-co-1287154"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Sotera Health Co. Hits New 52-Week High at $17.78

2025-11-05 16:52:12

Sotera Health Co. achieved a new 52-week high of USD 17.78 on November 4, 2025, marking a notable performance in the Pharmaceuticals & Biotechnology sector. The company has seen a 37.6% growth over the past year, with a P/E ratio of 36.00 and a return on equity of 19.00%.

Sotera Health Co. Hits New 52-Week High of $17.15

2025-10-27 17:02:23

Sotera Health Co. achieved a new 52-week high of USD 17.15 on October 24, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen a 41.21% growth over the past year and maintains a P/E ratio of 36.00 and a return on equity of 19.00%.

Sotera Health Co. Experiences Revision in Stock Evaluation Amid Market Dynamics

2025-10-14 16:30:41

Sotera Health Co., a small-cap in the Pharmaceuticals & Biotechnology sector, has seen a recent stock price increase to $15.67. Over the past year, it has returned 2.28%, while achieving a notable 129.43% return over three years. Technical indicators suggest a bullish trend, reflecting its market resilience.

Is Sotera Health Co. technically bullish or bearish?

2025-10-14 11:38:34

As of 10 October 2025, the technical trend for Sotera Health Co. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating a positive momentum. The Bollinger Bands are also showing a mildly bullish stance in both weekly and monthly time frames. However, the Dow Theory indicates a mildly bearish trend on the weekly chart, which adds some caution. In terms of returns, Sotera Health has outperformed the S&P 500 year-to-date with a return of 14.55% compared to 11.41%, but it has lagged over the past year with a return of 2.28% versus 13.36% for the index. Overall, the current technical stance is mildly bullish, driven by positive MACD and Bollinger Bands, despite some bearish signals from the Dow Theory and OBV....

Is Sotera Health Co. technically bullish or bearish?

2025-10-13 11:40:14

As of 10 October 2025, the technical trend for Sotera Health Co. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating a positive momentum. The Bollinger Bands also reflect a mildly bullish stance in both weekly and monthly time frames. However, the Dow Theory shows a mildly bearish signal on the weekly chart, and the On-Balance Volume is mildly bearish as well, suggesting some selling pressure. In terms of returns, Sotera Health has outperformed the S&P 500 year-to-date with a return of 12.21% compared to the S&P 500's 11.41%, but it has underperformed over the past year, returning only 0.99% versus the S&P 500's 13.36%. Overall, the current technical stance is mildly bullish, but with some mixed signals indicating caution....

Is Sotera Health Co. technically bullish or bearish?

2025-10-12 11:27:54

As of 10 October 2025, the technical trend for Sotera Health Co. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating a positive momentum. The Bollinger Bands are also showing a mildly bullish stance in both weekly and monthly time frames. However, the Dow Theory presents a mildly bearish signal on the weekly chart, and the On-Balance Volume (OBV) is mildly bearish as well, suggesting some selling pressure. In terms of performance, Sotera Health has underperformed the S&P 500 over the past week and month, with returns of -3.76% and -2.48% compared to -2.43% and 0.31% for the index, respectively. However, it has outperformed the S&P 500 year-to-date with a return of 12.21% versus 11.41%. Over three years, Sotera Health significantly outperformed the benchmark with a return of 120.55% compared to 81.39%. Overall, the current technical s...

Is Sotera Health Co. technically bullish or bearish?

2025-09-20 20:04:01

As of 28 August 2025, the technical trend for Sotera Health Co. has changed from mildly bullish to bullish. The current stance is bullish, with key indicators supporting this view including a bullish MACD on the weekly timeframe and bullish moving averages on the daily timeframe. However, the weekly RSI is bearish, indicating some short-term weakness. The company has a year-to-date return of 16.74%, outperforming the S&P 500's 12.22%, but it has underperformed over the past year with a return of -4.6% compared to the S&P 500's 17.14%. Overall, the strength of the bullish trend is supported by the weekly KST and Dow Theory both indicating bullish conditions....

Is Sotera Health Co. overvalued or undervalued?

2025-09-20 18:37:07

As of 7 July 2025, the valuation grade for Sotera Health Co. has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company appears overvalued based on its current metrics, with a P/E ratio of 36, a Price to Book Value of 8.52, and an EV to EBITDA of 10.60. In comparison, peers such as Lantheus Holdings, Inc. have a much lower P/E ratio of 10.13, and Haemonetics Corp. shows a more attractive EV to EBITDA of 10.38, highlighting the disparity in valuation. Recent stock performance shows that Sotera Health Co. has underperformed against the S&P 500 over the past year, with a return of -4.6% compared to the index's 17.14%. This underperformance, coupled with the elevated valuation ratios, reinforces the conclusion that Sotera Health Co. is overvalued in the current market environment....

View All News